Public disclosures

Kaplan Myron

Company insiders · Director · CorMedix Inc.

Advertisement
FollowLatest SEC filingSEC filer historyProfile details as reported on 2026-11-18.Following & alerts
Reported transaction lines
1
Buy lines
1
Sell lines
0

Filing activity by month

Original filing lines in up to 12 months with activity.

  • 2026-111

Frequently disclosed stocks

Disclosure history

More filters
Clear filters
Reporting investorSecurityActivityTransaction / periodFiledReported amountSource
Kaplan Myron

Director · CorMedix Inc.

CRMD

CorMedix Inc.

Buy
Filing details

SEC transaction code P

Common Stock · Direct ownership · Reported balance after transaction: 256487 · SEC code covers open-market or private transactions · This transaction was executed in multiple trades at prices ranging from $4.87 to $4.88, inclusive. The price reported in Column 4 is a weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transactions were effected.

2026-11-162026-11-18

≈ $122,000.00

25,000 shares/units

SEC 4

Counts describe original filing lines in BriefStock’s coverage. Later amendments can correct or supplement them. Check the original filing for ownership and transaction details.

Advertisement